Sulpiride and risperidone vs. [ldquo ]classical neuroleptics[rdquo ] in schizophrenia: a follow-up study

By Kogeorgos J.   Kanellos P.   Michalakeas A.   Ioannidis J.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 335-336

Elsevier

Access to resources Recommend Favorite

Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat

By Obuchowicz E.   Turchan J.  

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 51-59

Elsevier

Access to resources Recommend Favorite

The comparative effects of haloperidol, (-)-sulpiride, and SCH23390 on c-fos and c-jun mRNA expressions, and AP-1 DNA binding activity

By Ozaki T.   Katsumoto E.   Yokotani N.   Yamagami S.  

European Neuropsychopharmacology, Vol. 7, Iss. 3, 1997-08 ,pp. : 181-187

Elsevier

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Therapeutic Efficacy of Esmolol

By Wiest Donald B.   Haney Jason S.  

Clinical Pharmacokinetics, Vol. 51, Iss. 6, 2012-06 ,pp. : 347-356

Adis International

Access to resources Recommend Favorite

Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain

By Karolewicz B.   Antkiewicz-Michaluk L.   Michaluk J.   Vetulani J.  

European Journal of Pharmacology, Vol. 313, Iss. 3, 1996-10 ,pp. : 181-186

Elsevier

Access to resources Recommend Favorite